Circular Solutions for Life Sciences

klaro is a digital waste and resource management solution that gives companies greater transparency over their waste streams, costs and recycling processes. By combining operational waste management with data analysis, invoice verification and optimisation, klaro helps organisations reduce waste, improve recycling and keep valuable materials in circulation.

Presented by: Göknur Bektas, Founder & Managing Director

Deasyl is a Swiss deep-tech company developing innovative, sustainable chemical processes that transform industrial by-products, such as crude glycerol, into high-value, bio-based chemicals. Through circular chemistry, Deasyl reduces waste and carbon emissions while providing sustainable alternatives for industries including cosmetics, personal care, and life sciences.

Presented by: Olivier Enos, CEO

GreenCheck Biotech AG replaces the plastic housings and components of conventional lateral flow rapid tests with a patented, cellulose-based design made from up to 97% renewable materials. This cuts fossil-based plastic in single-use diagnostics and enables shorter, local supply chains. As a drop-in, OEM-ready solution for point-of-care testing across diagnostic fields, it gives the life sciences sector a direct way to reduce plastic waste without changing existing assay workflows.

Presented by: Javier Sánchez, CEO

Beyond Diagnostics is developing LUMIQ, a point-of-use test that verifies whether temperature-sensitive biologic medicines such as insulin are still effective before use. By helping avoid the unnecessary disposal and replacement of medicines whose quality is uncertain, LUMIQ supports more circular use of high-value life-science products, reducing pharmaceutical waste, resource consumption, and unnecessary cold-chain losses.

Presented by: Dr. Maren Schinz, CEO & Founder

Elio provides LCA data for pharmaceutical chemicals that are missing from leading LCA databases. Its auditable, deterministic and automated product carbon footprint calculation engine models synthetically made chemicals based on documented synthesis routes from patents and literature. By closing these data gaps, Elio enables pharmaceutical companies to integrate carbon impact into ecodesign and make more informed, lower-carbon choices when designing synthesis routes.

Presented by: Kami Krista, Co-founder & CEO

Prevision Medicine helps oncologists identify potentially effective treatments for individual patients by testing live cancer cells against hundreds of drugs. Its approach also explores off-label applications and new uses for existing medicines, helping uncover additional value from already available treatments.

Presented by: Dr. Philip Zimmermann, CEO